Davies Collison Cave | Australia | 16 Jul 2020
In the recent decision of Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd [2020] FCAFC 116, an enlarged bench of the Full Federal Court of Australia…
Davies Collison Cave | Australia | 5 May 2020
The Federal Court of Australia has rejected the Australian Government’s claim for $325 million in damages from Sanofi. The claim was made under a…
Davies Collison Cave | Australia | 20 Dec 2017
In a judgment handed down on 18 December 2017, Justice Beach of the Federal Court of Australia has questioned the appropriateness of a patent…
Davies Collison Cave | Australia, United Kingdom | 28 Nov 2016
In the recent decision of Apotex Pty Ltd v Warner-Lambert Company LLC (No 2) [2016] FCA 1238, the Federal Court has upheld the validity of Pfizer's…
Davies Collison Cave | Australia, Canada | 24 Feb 2014
Justice Robertson of the Federal Court of Australia has recently dismissed an appeal against the Commissioner of Patent's finding that key claims of a…
Davies Collison Cave | Australia | 5 Dec 2013
The Australian Federal Court has recently made orders preventing generic pharmaceutical company, Generic Health, from promoting and selling generic…
Davies Collison Cave | Australia | 15 Feb 2013
In a much anticipated judgment, on 15 February 2013, the Federal Court of Australia has confirmed that isolated nucleic acid (including isolated DNA…
Davies Collison Cave | Australia | 11 Sep 2012
Justice Jagot of the Federal Court has granted an interlocutory injunction prohibiting the promotion and sale of Apotex's generic versions of Merck's anti-allergic nasal spray, Nasonex.
Davies Collison Cave | Australia | 18 May 2012
Three Justices of the Federal Court of Australia have now on three separate occasions restrained Apotex's proposed launch of generic versions of Astra's cholesterol reducing statin, "Crestor" in Australia.
Davies Collison Cave | Australia | 28 Sep 2011
In a decision which considers both patent and copyright issues, the Federal Court recently found in favour of the patentee/originator, distinguishing between the purpose of administration and the result achieved in order to clarify construction of a method of treatment claim.